Cargando…

LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is often associated with the infection of Epstein-Barr virus in nasopharynx and is mainly happened in South China and Southeast Asia. Recently, noncoding RNAs have been reported to regulate NPC carcinogenesis. LncRNA OIP5-AS1 participates in tumorigenesis and progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuo, Tang, Mingxing, Zen, Nan, Liang, Junyi, Xing, Xiao, Huang, Danglin, Liu, Fei, Zhang, Xiaomeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214031/
https://www.ncbi.nlm.nih.gov/pubmed/35756672
http://dx.doi.org/10.3389/fonc.2022.921929
_version_ 1784730934986145792
author Li, Shuo
Tang, Mingxing
Zen, Nan
Liang, Junyi
Xing, Xiao
Huang, Danglin
Liu, Fei
Zhang, Xiaomeng
author_facet Li, Shuo
Tang, Mingxing
Zen, Nan
Liang, Junyi
Xing, Xiao
Huang, Danglin
Liu, Fei
Zhang, Xiaomeng
author_sort Li, Shuo
collection PubMed
description Nasopharyngeal carcinoma (NPC) is often associated with the infection of Epstein-Barr virus in nasopharynx and is mainly happened in South China and Southeast Asia. Recently, noncoding RNAs have been reported to regulate NPC carcinogenesis. LncRNA OIP5-AS1 participates in tumorigenesis and progression; however, the inherent mechanism of OIP5-AS1-mediated progression of NPC is unclear. In the current study, we aimed to explore the role of OIP5-AS1 in NPC progression. We measured the cell viability, apoptosis, migration, and invasion in NPC cells after OIP5-AS1 modulation. Moreover, we determined whether OIP5-AS1 exerts its oncogenic functions via sponging miR-183-5p in NPC. Furthermore, we determined whether glutamate ammonia ligase (GLUL) was a downstream target of miR-183-5p. We found that OIP5-AS1 downregulation inhibited the viability, migration and invasion of NPC via targeting miR-183-5p. We also identified that GLUL might be a potential downstream target of miR-183-5p in NPC cells. Mechanistically, OIP5-AS1 promotes cell motility via regulating miR-183-5p and GLUL in NPC cells. We concluded that OIP5-AS1 performed its biological functions via targeting miR-183-5p and GLUL in NPC cells.
format Online
Article
Text
id pubmed-9214031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92140312022-06-23 LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma Li, Shuo Tang, Mingxing Zen, Nan Liang, Junyi Xing, Xiao Huang, Danglin Liu, Fei Zhang, Xiaomeng Front Oncol Oncology Nasopharyngeal carcinoma (NPC) is often associated with the infection of Epstein-Barr virus in nasopharynx and is mainly happened in South China and Southeast Asia. Recently, noncoding RNAs have been reported to regulate NPC carcinogenesis. LncRNA OIP5-AS1 participates in tumorigenesis and progression; however, the inherent mechanism of OIP5-AS1-mediated progression of NPC is unclear. In the current study, we aimed to explore the role of OIP5-AS1 in NPC progression. We measured the cell viability, apoptosis, migration, and invasion in NPC cells after OIP5-AS1 modulation. Moreover, we determined whether OIP5-AS1 exerts its oncogenic functions via sponging miR-183-5p in NPC. Furthermore, we determined whether glutamate ammonia ligase (GLUL) was a downstream target of miR-183-5p. We found that OIP5-AS1 downregulation inhibited the viability, migration and invasion of NPC via targeting miR-183-5p. We also identified that GLUL might be a potential downstream target of miR-183-5p in NPC cells. Mechanistically, OIP5-AS1 promotes cell motility via regulating miR-183-5p and GLUL in NPC cells. We concluded that OIP5-AS1 performed its biological functions via targeting miR-183-5p and GLUL in NPC cells. Frontiers Media S.A. 2022-06-08 /pmc/articles/PMC9214031/ /pubmed/35756672 http://dx.doi.org/10.3389/fonc.2022.921929 Text en Copyright © 2022 Li, Tang, Zen, Liang, Xing, Huang, Liu and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Shuo
Tang, Mingxing
Zen, Nan
Liang, Junyi
Xing, Xiao
Huang, Danglin
Liu, Fei
Zhang, Xiaomeng
LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title_full LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title_fullStr LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title_full_unstemmed LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title_short LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma
title_sort lncrna oip5-as1 knockdown targets mir-183-5p/glul axis and inhibits cell proliferation, migration and metastasis in nasopharyngeal carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214031/
https://www.ncbi.nlm.nih.gov/pubmed/35756672
http://dx.doi.org/10.3389/fonc.2022.921929
work_keys_str_mv AT lishuo lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT tangmingxing lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT zennan lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT liangjunyi lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT xingxiao lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT huangdanglin lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT liufei lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma
AT zhangxiaomeng lncrnaoip5as1knockdowntargetsmir1835pglulaxisandinhibitscellproliferationmigrationandmetastasisinnasopharyngealcarcinoma